Company Analysis National Health Investors, Inc.
1. Summary
Advantages
- Dividends (5.12%) are higher than the sector average (3.21%).
- The stock's return over the last year (19.88%) is higher than the sector average (-31.58%).
- The company's current efficiency (ROE=10.82%) is higher than the sector average (ROE=6.02%)
Disadvantages
- Price (73.81 $) is higher than fair price (34.96 $)
- Current debt level 48.64% has increased over 5 years from 47.7%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| National Health Investors, Inc. | Real Estate | Index | |
|---|---|---|---|
| 7 days | -2.3% | -12.9% | 0.6% |
| 90 days | 6.4% | -35.6% | -4.3% |
| 1 year | 19.9% | -31.6% | 9.3% |
NHI vs Sector: National Health Investors, Inc. has outperformed the "Real Estate" sector by 51.46% over the past year.
NHI vs Market: National Health Investors, Inc. has outperformed the market by 10.6% over the past year.
Stable price: NHI is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NHI with weekly volatility of 0.3823% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (73.81 $) is higher than the fair price (34.96 $).
Price is higher than fair: The current price (73.81 $) is 52.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (18.19) is lower than that of the sector as a whole (61.35).
P/E vs Market: The company's P/E (18.19) is lower than that of the market as a whole (73.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.94) is higher than that of the sector as a whole (-0.8993).
P/BV vs Market: The company's P/BV (1.94) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (7.71) is higher than that of the sector as a whole (7.68).
P/S vs Market: The company's P/S indicator (7.71) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.5) is lower than that of the sector as a whole (20.69).
EV/Ebitda vs Market: The company's EV/Ebitda (14.5) is lower than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.34% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.34%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (12.56%).
5.4. ROE
ROE vs Sector: The company's ROE (10.82%) is higher than that of the sector as a whole (6.02%).
ROE vs Market: The company's ROE (10.82%) is lower than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (5.45%) is higher than that of the sector as a whole (3.74%).
ROA vs Market: The company's ROA (5.45%) is lower than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (3.86%) is lower than that of the sector as a whole (6.96%).
ROIC vs Market: The company's ROIC (3.86%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.12% is higher than the average for the sector '3.21%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.12% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 5.12% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (115.17%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
